Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07138261) titled 'Taiwanese Anaplastic Thyroid Cancer Registry' on Aug. 3.

Study Type: Observational

Primary Sponsor: National Health Research Institutes, Taiwan

Condition: Thyroid Carcinoma, Anaplastic

Recruitment Status: Not recruiting

Date of First Enrollment: September 1, 2025

Target Sample Size: 100

Countries of Recruitment: Taiwan

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07138261

Published by HT Digital Content Services with permission from Health Daily Digest....